Non-invasive imaging biomarkers (IBs) are warranted to enable improved diagnostics and
follow-up monitoring of interstitial lung disease (ILD) including drug-induced ILD (DIILD). Of …

Objective Accurate imaging biomarkers that indicate disease progression at an early stage
are highly important to enable timely mitigation of symptoms in progressive lung disease. In …

There is a large unmet need for a simple, accurate, noninvasive, quantitative, and high-
resolution imaging modality to detect lung fibrosis at early stage and to monitor disease …

Pulmonary fibrosis is scarring of the lungs that can arise from radiation injury, drug toxicity,
environmental or genetic causes, and for unknown reasons [idiopathic pulmonary fibrosis …

A fluorinated analog of proline amino acid, cis-4-[18F] fluoro-l-proline (FP), was tested for
potential use in PET for detection and evaluation of pulmonary response to respirable …

Idiopathic pulmonary fibrosis is characterized by a progressive and irreversible respiratory
failure. Validated noninvasive methods able to assess disease activity are essential for …

Idiopathic pulmonary fibrosis (IPF) is a fatal lung disease characterized by the progressive
and irreversible destruction of lung architecture, which causes significant deterioration in …

Purpose Idiopathic pulmonary fibrosis (IPF) is a destructive lung disease with a poor
prognosis, an unpredictable clinical course, and inadequate therapies. There are currently …

Purpose The lack of effective molecular biomarkers to monitor idiopathic pulmonary fibrosis
(IPF) activity or treatment response remains an unmet clinical need. Herein, we determined …

A large number of systemically administered drugs have the potential to cause drug-induced
interstitial lung disease (DIILD). We aim to characterize a model of DIILD in the rat and …